Jack Stover | President and Chief Executive Officer |
Jim Early | Chief Financial Officer |
Kevin DeGeeter | Ladenburg Thalmann |
François Brisebois | Laidlaw |
Yi Chen | H.C. Wainwright |
Naureen Quibria | Maxim Group |
David Reed | Morgan Stanley |
Lauren Chung | Westpark Capital |
Good afternoon, everyone, and thank you for joining us for the Interpace Diagnostics Conference Call to review the Company’s Financial Results and Operations for the Second Quarter and Year-to-date of 2018 as well as Recent Developments. The earnings release detailing second quarter results was issued after the close of the market today and should be available on Interpace’s website at www.interpacediagnostics.com.
Before we get started, during the course of this conference call, the company will make forward-looking statements. We caution you that any statement that is not a statement of historical fact is a forward-looking statement. This includes remarks about the company’s financial projections, expectations, plans, beliefs and prospects.